Clinical Trials

Phase I Studies
RP5063 phase 1B in stable schizophrenia patients — completed
RP5063 phase 1A study in healthy subjects — completed

Phase II Studies

RP5063 phase II study in schizophrenia and schizoaffective disorder patients– completed

Phase III Studies

RP5063 phase III study in acute schizophrenia patients — in preparation
RP5063 phase III study in stable (maintenance phase) schizophrenia patients — in preparation